Aragen Life Sciences

#polloftheday #drugresearch #drugdevelopment #drugdiscovery

As we reflect on Aragen's journey, we are filled with gratitude for everyone who has been part of our success. To our dedicated employees, trusted clients, and valued partners; thank you for your unwavering support, trust, and collaboration. Together, we’ve achieved remarkable milestones, driven innovation, and made a meaningful impact in advancing scientific solutions. Your contributions inspire us to aim higher, innovate further, and continue to deliver excellence. Here’s to many more achievements, shared successes, and meaningful partnerships. Wishing you all a warm and joyful Thanksgiving! #thanksgiving #happythanksgiving #thanksgiving2024

At Aragen, we specialize in advancing clinical candidates with end-to-end formulation solutions tailored to overcome complex development challenges. Our scientific expertise and state-of-the-art formulation and analytical laboratories enable us to:   ◾ Resolve solubility, in vivo exposure, solid form, and stability challenges.    ◾ Develop innovative technologies and dosage forms for various routes of administration.  ◾ Guide difficult-to-develop drug molecules seamlessly from preclinical and clinical phases to market readiness.   Our multidisciplinary approach ensures the creation of optimal dosage forms while conserving precious drug substances. With a dedicated technology transfer team, we facilitate smooth manufacturing and regulatory support for clinical studies. Partner with us to progress your drug candidates with speed, cost-efficiency, and quality. Write to us at [email protected] to connect with our experts. #drugdiscovery #drugsubstance #drugdevelopment #drugformulations #cdmo #cro #pharmaservices #endtoendsolutions #preclinical

At Aragen, we believe in the power of connected solutions to drive efficient and effective drug discovery. Our integrated partnership approach enables us to collaborate seamlessly with customers, ensuring the swift progression of molecules through early-phase discovery. Here’s how we make it happen:   ◾ Multidisciplinary expertise: Multidisciplinary scientists from chemistry, biology, and pharmacology collaborate seamlessly to address program challenges.   ◾ Tailored solutions: Custom team structures aligned with project needs and timelines.  ◾ Focused leadership: Dedicated project leads drive efficiency and outcomes.  Efficient project management: Our XLRATE platform streamlines workflows and ensures timely communication. With speed, scientific rigor, flexibility, and data integrity as our hallmarks, we partner with customers to advance programs through critical decision milestones and deliver IND-ready candidates. Together, let’s turn discovery into breakthrough success, write to us at [email protected] to connect with our experts. #drugdiscovery #drugresearch #indfiling #earlyphase #cdmo #cro #pharmaservices #pharmacology #endtoendsolutions

In a recent interview with Speciality Chemicals Magazine, Dr. Chandan Shirbhayye , VP & Head Supply Chain at Aragen shared his insights on how the global supply chain is evolving and how pharmaceutical companies are shifting away from heavy reliance on China for raw materials and intermediates. He also highlighted how Aragen is helping clients build more resilient and sustainable supply chains through local sourcing and strategic partnerships with Indian startups. By focusing on backward integration, hyper-local sourcing, and integrating AI/ML into procurement, we are improving efficiency, and reducing carbon emissions. The company’s efforts have resulted in significant cost reductions and enhanced supply chain stability, positioning it as a key players in the diversified global supply chain landscape. To read full article click on the link https://lnkd.in/djc-R688 #supplychain #greensupply #carbonemissions #sustainablesupplychain #ai #machinelearning #rawmaterials #procurement #localsourcing #cdmo #cro #pharmaservices #indianpharma

At Aragen, we are dedicated to advancing oncology research by offering comprehensive pre-clinical efficacy testing solutions designed to accelerate the development of breakthrough cancer therapies. Our expertise spans validated tumor models, including cell-line-derived xenografts (CDX), robust capabilities in imaging, biomarker analysis, and pharmacokinetics, and support for diverse therapeutic modalities like small molecules, biologics, and combination therapies. With tailored study designs and a focus on precision, we empower our partners to navigate the complexities of oncology drug development with speed and confidence. Together, we aim to make a meaningful difference in the fight against cancer. To know more about our services or to schedule a meeting with our experts write to us at [email protected]   #oncologyresearch #drugdevelopment #biomarkers #biologics #preclinical #cdmo #cro #pharmaservices #xenografts #efficacytesting

In conversation with Dan Stanton from BioProcess International, at CPHI Milan; our CCO, Ashu Tandon shared his views on the evolving global biopharma supply chain ecosystem. He highlighted, R&D programs are transitioning rapidly, with many customers exploring partnerships, conducting site audits, and initiating pilot projects to build resilient supply chains. On the manufacturing side, the shift is slower but deliberate, as regulatory complexities and validation requirements take precedence. Beyond the BIOSECURE Act, the Inflation Reduction Act (IRA) is also influencing the industry, pushing companies to seek cost-efficient, high-quality solutions. This dual impact underscores the growing importance of India as a global hub for biopharma innovation. To read the complete conversation click on the link https://lnkd.in/gkxDe8gu #mediacoverage #industryupdate #news #biosecure #Inflationreductionact #drugdiscovery #drugdevelopment #cdmo #cro #pharmaservices #drugmanufacturing #indianpharma

At Aragen, we pride ourselves on advancing drug discovery programs with efficiency and precision. Our team is committed to delivering tailored solutions designed to streamline the entire drug discovery process. From in vitro assay development to ADME/PK profiling and in vivo pharmacology studies, our capabilities span the entire drug discovery continuum:  ◾ Customized in vitro assay development and high-throughput screening to identify potential drug candidates efficiently. ◾ Absorption, distribution, metabolism, and excretion (ADME) studies along with pharmacokinetic (PK) profiling to understand the drug's behavior in the body. ◾ In vivo studies to evaluate the efficacy and safety of drug candidates. ◾ With our GLP-certified facility, we provide regulatory safety assessments and bioanalytical services to support regulatory submissions. ◾ We ensure reliable and reproducible analytical data to support speedy filing for regulatory approval. ◾ Offer comprehensive reagent generation services including recombinant protein production, cell line development, and monoclonal antibody production, supporting drug discovery and development. With a seamless blend of scientific expertise and integrated approach, we’re here to accelerate your journey from concept to commercialization. At Aragen, we don’t just support your programs, we partner with you to shape the future of drug discovery. Write to us at [email protected] to schedule a call with our experts. #drugdiscovery #clinical #preclinical #cdmo #cro #invivo #pharmacology #monoclonal #antibody

In a BioVoice News interview, SHIVAJI JADHAV, VP & Head - EHS & Sustainability at Aragen Life Sciences, highlighted our commitment to sustainability through ambitious net-zero targets, 100% renewable energy adoption, and over $1.5M investment in green initiatives. With a focus on ESG goals, sustainable sourcing, and innovative practices, Aragen is shaping a greener future for biotech while driving impactful solutions. Click on the link https://lnkd.in/gYEsZ8YB to read the full article. #newsupdate #sustainability #biotechs #cdmo #cro #pharmafuture #netzero #esggoals #greenfuture #greenchemicals #drugdiscovery #drugmanufacturing #drugdevelpment #decarbonizing #greensupplychain

We are excited to welcome Jada Fernandez who recently joined our North America Business Development team for Discovery Services. Jada joins us after successful stints at BioDuro-Sundia and WuXi AppTec. Jada is based in San Diego and will focus on growing our business footprint in Southern California and neighbouring western states. She has a bachelor’s degree in biology from San Francisco State University. Jada says that "As a passionate advocate for patients in need, I'm excited for the opportunity to support our partners in driving their drug discovery research forward and gaining valuable insights in the field." We once again welcome to the Aragen’s family, Jada ! #businessdevelopment #newinteam #northamerica #westcoast #drugdiscovery #biologics #cdmo #cro #pharmaservices #california